Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to 24.63.

  • Ocular Therapeutix's Interest Coverage Ratio fell 5127.61% to 24.63 in Q4 2025 from the same period last year, while for Dec 2025 it was 22.82, marking a year-over-year decrease of 8033.77%. This contributed to the annual value of 22.82 for FY2025, which is 8032.32% down from last year.
  • Per Ocular Therapeutix's latest filing, its Interest Coverage Ratio stood at 24.63 for Q4 2025, which was down 5127.61% from 22.88 recorded in Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's Interest Coverage Ratio peaked at 4.83 during Q4 2023, and registered a low of 24.63 during Q4 2025.
  • For the 5-year period, Ocular Therapeutix's Interest Coverage Ratio averaged around 13.42, with its median value being 12.02 (2022).
  • As far as peak fluctuations go, Ocular Therapeutix's Interest Coverage Ratio skyrocketed by 5392.12% in 2023, and later tumbled by 23711.76% in 2024.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Interest Coverage Ratio stood at 10.74 in 2021, then rose by 2.43% to 10.48 in 2022, then soared by 53.92% to 4.83 in 2023, then crashed by 237.12% to 16.28 in 2024, then plummeted by 51.28% to 24.63 in 2025.
  • Its Interest Coverage Ratio was 24.63 in Q4 2025, compared to 22.88 in Q3 2025 and 22.43 in Q2 2025.